MA (Oxon) in Biochemistry, DPhil (Neuroscience), Chartered Patent Attorney, European Patent Attorney.
Steve specialises in biotechnology inventions, with particular expertise in therapeutic/diagnostic antibodies and disease biomarkers. He has extensive experience of patent prosecution at the European Patent Office, including oppositions and appeals, and has also supported national patent litigation in the UK and Scandinavia.
Steve acts for a range of clients including multinational companies, early-stage and established biotech companies based throughout Europe, as well as government-funded research institutes and universities.
Steve read Biochemistry at the University of Oxford before undertaking a doctorate degree in Neuroscience. After completing his doctorate, Steve remained in Oxford and spent three years as a post-doctoral scientist, authoring a number of scientific papers.
Steve joined Potter Clarkson in 1998 and became a Partner in 2007. He became Managing Partner in January 2019.
He has lectured and written numerous articles on the patenting of biotechnological inventions. Clients praise Steve for his broad scientific knowledge, keen advocacy skills and pragmatic commercial advice.